syrosingopine has been researched along with Kahler Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ates, G; De Bruyne, E; De Veirman, K; Faict, S; Fan, R; Maes, A; Massie, A; Menu, E; Oudaert, I; Satilmis, H; Van der Vreken, A; Vanderkerken, K; Vlummens, P | 1 |
1 other study(ies) available for syrosingopine and Kahler Disease
| Article | Year |
|---|---|
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Lactic Acid; Metformin; Monocarboxylic Acid Transporters; Multiple Myeloma | 2023 |